申请人:Taisho Pharmaceutical Co., Ltd.
公开号:US04557871A1
公开(公告)日:1985-12-10
Novel styrene derivatives of the general formula ##STR1## wherein X is hydrogen or halogen, X.sup.1 is halogen, R is hydrogen or methyl, Y is hydroxymethyl, carboxyl, --COOR.sup.1 or --COR.sup.2 wherein R.sup.1 is prenyl, geranyl, farnesyl, cyclohexyl, phthalidyl, straight or branched chain alkyl having 1 to 6 carbon atoms, or said alkyl substituted with hydroxy, methoxy, pyridyl or alkanoyloxy having 2 to 16 carbon atoms, and R.sup.2 is amino, hydroxyamino mono-(or di-)alkylamino in which the alkyl moiety contains 1 or 2 carbon atoms, ethoxycarbonylmethylamino, carboxymethylamino, thiazolylamino, cyclohexylamino, pyridylamino, morpholino, N-methylpiperazino, phenylamino, phenylamino substituted with one or two of halogen, hydroxy, methyl, methoxy, trifluoromethyl or carboxyl at the phenyl ring, and the pharmaceutically acceptable salts thereof when Y is carboxyl are disclosed. These compounds exhibit high and long-lasting anti-inflammatory, analgesic and anti-pyretic activity.
一种新型苯乙烯衍生物,其一般式为##STR1##其中X为氢或卤素,X.sup.1为卤素,R为氢或甲基,Y为羟甲基、羧基、--COOR.sup.1或--COR.sup.2,其中R.sup.1为异戊烯基、蒎烯基、法尼烯基、环己基、邻苯二甲酰基、含有1至6个碳原子的直链或支链烷基,或者该烷基被氢氧基、甲氧基、吡啶基或含有2至16个碳原子的烷酰氧基取代,R.sup.2为氨基、羟氨基、单(或双)烷基氨基,其中烷基部分含有1或2个碳原子,乙氧羰基甲基氨基,羧甲基氨基,噻唑基氨基,环己基氨基,吡啶基氨基,吗啉基,N-甲基哌嗪基,苯基氨基,苯基氨基,苯环上取代有一个或两个卤素、羟基、甲基、甲氧基、三氟甲基或羧基的苯基氨基,以及其在Y为羧基时的药用盐被披露。这些化合物表现出高效且持久的抗炎、镇痛和退热活性。